Christopher Ryan Sullivan
Chief Financial Officer · 8 filings · Latest: Jun 10, 2026
Avalo Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | May 7, 2026 | Sale | $24.12 | 18,606 | $448.8K | 423 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | May 7, 2026 | Option Exercise | $9.88 | 18,606 | $183.8K | 19,029 | |
AVTX | CHRISTOPHER SULLIVAN | — | May 7, 2026 | Proposed Sale | $21.81 | 18,606 | $405.8K | — | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | May 6, 2026 | Sale | $20.19 | 47,000 | $948.7K | 423 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | May 6, 2026 | Option Exercise | $8.04 | 47,000 | $377.9K | 47,423 | |
AVTX | CHRISTOPHER SULLIVAN | — | May 6, 2026 | Proposed Sale | $16.26 | 47,000 | $764.2K | — | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Apr 30, 2026 | Sale | $13.23 | 8,457 | $111.9K | 423 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Apr 29, 2026 | Sale | $13.09 | 8,458 | $110.7K | 8,880 | |
AVTX | CHRISTOPHER SULLIVAN | — | Apr 29, 2026 | Proposed Sale | $12.86 | 16,915 | $217.5K | — | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Apr 2, 2026 | Sale | $17.15 | 7,980 | $136.8K | 17,338 | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Apr 1, 2026 | Sale | $16.77 | 7,979 | $133.8K | 25,318 | |
AVTX | CHRISTOPHER SULLIVAN | — | Apr 1, 2026 | Proposed Sale | $14.93 | 15,959 | $238.3K | — | |
AVTX | Christopher Ryan Sullivan | Chief Financial Officer | Mar 28, 2026 | Option Exercise | — | 24,200 | — | 41,538 |